The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
me change notification emails
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
Funding Opportunity Number:
Feb 14, 2013
Feb 14, 2013
Original Closing Date for Applications:
Apr 05, 2013
Current Closing Date for Applications:
Apr 05, 2013
May 05, 2013
Funding Instrument Type:
Category of Funding Activity:
Expected Number of Awards:
Estimated Total Program Funding:
Substance Abuse and Mental Health Services_Projects of Regional and National Significance
Cost Sharing or Matching Requirement:
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
SAMHSA is limiting eligibility for this program to SAMHSA certified non-profit opioid treatment programs (OTP) because OTPs are optimal settings in which to provide comprehensive hepatitis prevention and control services. The majority of OTP clients have a history of injecting drugs, placing them at high risk for human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and viral hepatitis. OTPs provide hepatitis C counseling, testing, treatment, and hepatitis A and B vaccinations, retain clients for extended periods of time, and have licensed medical facilities with medical staff. Only certified OTPs may apply because only they are qualified to provide opioid treatment under 42 CFR part 8. The statutory authority for this program prohibits grants to for-profit agencies.
Substance Abuse & Mental Health Services Adminis.
The purpose of this program is to address the high prevalence of viral hepatitis C infection among IV drug users in selected opioid treatment programs (OTPs). In addition to providing rapid hepatitis C virus (HCV) testing, applicants must develop a plan for providing referrals for care and treatment that include, but are not limited to primary health care, public health, mental health, and medical services for those who are HCV positive or are at high-risk of HCV infection.